Two new ventures strike deals with drug makers to combat generic shortages

first_img Underscoring concerns about ongoing drug shortages, two different ventures representing hundreds of hospitals across the U.S. are announcing separate deals on Wednesday in which manufacturers have agreed to provide medicines that are in short supply.In the first deal, CivicaRx, which is a generic drug company formed by several large hospital systems and three philanthropies, has reached an agreement for Xellia Pharmaceuticals to manufacture antibiotics, including vancomycin and daptomycin. The deal marks the first such arrangement since CivicaRx launched several months ago. About 900 hospitals are part of the CivicaRx network. Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Ed Silverman Bottles of prescription drugs are filled at the central pharmacy of Intermountain Heathcare, a member of CivicaRx. George Frey/Getty Images By Ed Silverman May 15, 2019 Reprints Pharmalot [email protected] STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. What’s included? About the Author Reprintscenter_img Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. What is it? Pharmalot Columnist, Senior Writer Ed covers the pharmaceutical industry. Log In | Learn More GET STARTED Two new ventures strike deals with drug makers to combat generic shortages @Pharmalot Tags drug pricinghospitalspharmaceuticalsSTAT+last_img read more